# Eton Pharmaceuticals

Type: Company (ETON)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/eton-pharmaceuticals
Canonical HTML page: https://getfinancebrief.com/entity/eton-pharmaceuticals

## Timeline

- **2026-09-03**: Jefferson Capital dividend payable — Quarterly cash dividend of $0.24 per share is payable to shareholders.
- **2026-08-24**: Jefferson Capital dividend record date — Shareholders of record at close of business on August 24, 2026 qualify for the $0.24 per share dividend.
- **2026-08-13**: Q2 2026 earnings releases — Eton, Dawson, and Jefferson Capital report Q2 2026 financial results, with releases distributed at 20:30 UTC.
- **2026-06-30**: Q2 2026 reporting period ends — Eton Pharmaceuticals, Dawson Geophysical, and Jefferson Capital close the second quarter ended June 30, 2026.
- **2026-05**: HEMANGEOL relaunch — Eton relaunches HEMANGEOL in May 2026 with full Eton Cares patient support, including $0 copay for eligible patients.

## Recent coverage (1 stories)

### Q2 2026: Eton +99% Rev, Dawson +82%, Jefferson $0.24 Div
2026-08-13 22:06:46 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Three Q2 2026 earnings releases from Eton Pharmaceuticals, Dawson Geophysical, and Jefferson Capital show strong revenue growth but uneven profitability. Finance readers should focus on revenue catalysts, margin expansion, and dividend sustainability.
Full story: https://getfinancebrief.com/story/small-cap-q2-2026-earnings-eton-dawson-jefferson

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.